Lupin Receives FDA Approval For Amlodipine/Benazepril Capsules

The Amlodipine/Benazepril capsules are the AB rated generic equivalent of Novartis’ Lorrel capsules indicated for the treatment of hypertension.

Nilesh Gupta, group president and executive director of Lupin, said: “We are very pleased with the approval of our Amlodipine/ Benazepril capsules. This is a significant approval and it broadens our growing portfolio of cariovascular medication with complement to our existing product line. The approval reflects the confidence and acceptance of our facility by the FDA, as well as our unwavering commitment to quality and to bringing important products to market.”

Amlodipine/Benazepril is a combination of two blood pressure medicines, an angiotensin-converting enzyme (ACE) inhibitor and a calcium channel blocker. It works by helping blood vessels relax (dilate) and lower blood pressure.